CN Patent

CN110215440A — 昼夜节律紊乱的治疗

Assigned to Vanda Pharmaceuticals Inc · Expires 2019-09-10 · 7y expired

What this patent protects

本发明涉及昼夜节律紊乱的治疗。本发明的实施方式涉及褪黑素激动剂在治疗患者(包括光感损伤的患者，例如，失明患者)的自由运转的昼夜节律中的用途，以及测量昼夜节律的方法。

USPTO Abstract

本发明涉及昼夜节律紊乱的治疗。本发明的实施方式涉及褪黑素激动剂在治疗患者(包括光感损伤的患者，例如，失明患者)的自由运转的昼夜节律中的用途，以及测量昼夜节律的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN110215440A
Jurisdiction: CN
Classification: —
Expires: 2019-09-10
Drug substance claim: No
Drug product claim: No
Assignee: Vanda Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.